• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T3 声门型喉癌的外科治疗:长期结果与决策分析。

Primary surgical treatment of T3 glottic carcinoma: long-term results and decision-making aspects.

机构信息

Department of Otorhinolaryngology-Head and Neck Surgery, University of Erlangen-Nuremberg, Erlangen, Germany.

出版信息

Laryngoscope. 2012 Dec;122(12):2723-7. doi: 10.1002/lary.23580. Epub 2012 Sep 10.

DOI:10.1002/lary.23580
PMID:22965857
Abstract

OBJECTIVES/HYPOTHESIS: The aim of this study was to assess the efficacy of primary surgical treatment in the management of T3 glottic carcinomas.

STUDY DESIGN

Retrospective clinical study.

METHODS

A retrospective evaluation of the records for all patients treated with primary surgery for T3 glottic carcinomas at a tertiary referral center between 1980 and 2005 was carried out. Data for the 5-year disease-specific survival (DSS) were assessed, as well as local control rates in relation to vocal cord immobility, N classification, choice of surgical modality, and adjuvant therapy. Patients who underwent partial laryngectomy were also evaluated in relation to organ preservation and the rate of permanent tracheotomies.

RESULTS

The 5-year DSS in the 120 patients was 78.3%. Positive neck disease was shown to be a significant negative prognostic factor. Organ preservation was achieved in 90.1% of the patients who underwent partial laryngectomy and in 50% of the overall patient group. The occult metastasis rate was 14%.

CONCLUSIONS

Primary surgical treatment is an effective modality against T3 glottic carcinomas. Partial laryngectomy is a reliable method in carefully selected cases. Low complication rates can be expected.

摘要

目的/假设:本研究旨在评估原发性手术治疗 T3 声门型喉癌的疗效。

研究设计

回顾性临床研究。

方法

对 1980 年至 2005 年间在一家三级转诊中心接受原发性手术治疗 T3 声门型喉癌的所有患者的记录进行了回顾性评估。评估了 5 年疾病特异性生存率(DSS),以及与声带固定、N 分类、手术方式选择和辅助治疗相关的局部控制率。还评估了接受部分喉切除术的患者与器官保留和永久性气管切开术的发生率之间的关系。

结果

120 例患者的 5 年 DSS 为 78.3%。颈部疾病阳性被证明是一个显著的预后不良因素。接受部分喉切除术的患者中有 90.1%实现了器官保留,而在整个患者组中这一比例为 50%。隐匿性转移率为 14%。

结论

原发性手术治疗是治疗 T3 声门型喉癌的有效方法。在精心选择的病例中,部分喉切除术是一种可靠的方法。预计并发症发生率低。

相似文献

1
Primary surgical treatment of T3 glottic carcinoma: long-term results and decision-making aspects.T3 声门型喉癌的外科治疗:长期结果与决策分析。
Laryngoscope. 2012 Dec;122(12):2723-7. doi: 10.1002/lary.23580. Epub 2012 Sep 10.
2
Management of T3N0M0 glottic carcinoma: therapeutic outcomes.T3N0M0声门癌的治疗:治疗结果
Laryngoscope. 2002 Jul;112(7 Pt 1):1281-8. doi: 10.1097/00005537-200207000-00026.
3
[Selection of surgical modalities for T3 glottic carcinoma].[T3 声门癌手术方式的选择]
Zhonghua Zhong Liu Za Zhi. 2011 Nov;33(11):860-3.
4
Management of stage IV glottic carcinoma: therapeutic outcomes.IV期声门癌的治疗:治疗结果
Laryngoscope. 2004 Aug;114(8):1438-46. doi: 10.1097/00005537-200408000-00024.
5
Management of T3N1 glottic carcinoma: therapeutic outcomes.T3N1期声门癌的治疗:治疗结果
Laryngoscope. 2006 Jan;116(1):106-10. doi: 10.1097/01.mlg.0000184767.62682.3d.
6
Long-term observations and salvage operations on patients with T2N0M0 squamous cell carcinoma of the glottic larynx treated with radiation therapy alone.对仅接受放射治疗的声门型喉鳞状细胞癌T2N0M0患者的长期观察及挽救性手术
Acta Otolaryngol. 2012 May;132(5):546-51. doi: 10.3109/00016489.2011.646008. Epub 2012 Jan 21.
7
[Treatment and prognosis of stage T3 glottic laryngeal cancer--a report of 65 cases].T3期声门型喉癌的治疗与预后——附65例报告
Ai Zheng. 2006 Jan;25(1):85-7.
8
The management of glottic and supraglottic cancers of the larynx in relation to neck metastasis.喉声门和声门上区癌与颈部转移相关的治疗
Kulak Burun Bogaz Ihtis Derg. 2003 Nov;11(5):129-33.
9
Local control after supracricoid partial laryngectomy for "advanced" endolaryngeal squamous cell carcinoma classified as T3.环杓上部分喉切除术治疗分类为T3的“晚期”喉内鳞状细胞癌后的局部控制情况
Arch Otolaryngol Head Neck Surg. 2004 Sep;130(9):1092-9. doi: 10.1001/archotol.130.9.1092.
10
Endoscopic vertical partial laryngectomy.内镜下垂直部分喉切除术
Laryngoscope. 2004 Feb;114(2):236-40. doi: 10.1097/00005537-200402000-00012.

引用本文的文献

1
Surgery of T1/2 N0 M0 glottic cancer results in a better laryngeal preservation time compared to radiotherapy in a large German patient cohort.在一个大型德国患者队列中,与放射治疗相比,T1/2 N0 M0声门癌手术可带来更长的喉保留时间。
Eur Arch Otorhinolaryngol. 2025 Jun 14. doi: 10.1007/s00405-025-09460-3.
2
[Clinical treatment strategy for pT3N0 laryngeal squamous cell carcinoma].[pT3N0期喉鳞状细胞癌的临床治疗策略]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2025 Jan;39(1):61-65. doi: 10.13201/j.issn.2096-7993.2025.01.013.
3
Comparison of Treatment Outcomes for T3 Glottic Squamous Cell Carcinoma: A Meta-Analysis.
T3 声门鳞状细胞癌治疗结果的比较:一项荟萃分析
Clin Exp Otorhinolaryngol. 2018 Mar;11(1):1-8. doi: 10.21053/ceo.2017.00717. Epub 2018 Feb 22.
4
Evidence and evidence gaps of laryngeal cancer surgery.喉癌手术的证据与证据空白
GMS Curr Top Otorhinolaryngol Head Neck Surg. 2016 Dec 15;15:Doc03. doi: 10.3205/cto000130. eCollection 2016.
5
Adenoid cystic carcinoma of the larynx: A report of two cases.喉腺样囊性癌:两例报告。
Oncol Lett. 2015 Oct;10(4):2303-2306. doi: 10.3892/ol.2015.3550. Epub 2015 Jul 30.
6
microRNA-423-3p promotes tumor progression via modulation of AdipoR2 in laryngeal carcinoma.微小RNA-423-3p通过调节脂联素受体2促进喉癌肿瘤进展。
Int J Clin Exp Pathol. 2014 Aug 15;7(9):5683-91. eCollection 2014.
7
Assessing quality of life in patients after partial laryngectomy.评估部分喉切除术后患者的生活质量。
Hippokratia. 2014 Apr;18(2):156-61.
8
Primary surgical therapy for locally limited oral tongue cancer.局部局限性口腔舌癌的原发性手术治疗。
Biomed Res Int. 2014;2014:738716. doi: 10.1155/2014/738716. Epub 2014 May 20.
9
Management of advanced laryngeal cancer.晚期喉癌的管理
Rambam Maimonides Med J. 2014 Apr 28;5(2):e0015. doi: 10.5041/RMMJ.10149. eCollection 2014 Apr.